| Trial ID: | L6602 |
| Source ID: | NCT03479671
|
| Associated Drug: |
Intralipid, 20% Intravenous Emulsion
|
| Title: |
Low Dose Fat-Induced Insulin Resistance
|
| Acronym: |
BCAA
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Insulin Resistance|Insulin Sensitivity
|
| Interventions: |
DRUG: Intralipid, 20% Intravenous Emulsion
|
| Outcome Measures: |
Primary: Insulin Sensitivity, Rate of Glucose Disposal (mg/kg/min), 6 hours |
|
| Sponsor/Collaborators: |
Sponsor: University of Pennsylvania
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2020-01-01
|
| Completion Date: |
2026-01
|
| Results First Posted: |
|
| Last Update Posted: |
2025-03-11
|
| Locations: |
University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03479671
|
